In a major healthcare reform, Uttar Pradesh Chief Minister Yogi Adityanath mandates complete digitalization of drug regulation system and stricter quality control measures to ensure medicine safety across the state.
Exclusive: Veteran Bollywood actor Parmeet Sethi decodes the economics of YouTube vs traditional entertainment, revealing how vlogging provides lifelong premium earnings.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Delhi High Court puts temporary stay on NPPA's order restricting 'ORS' branding for manufacturers. JJ Arm and other companies get breathing room in crucial rehydration market.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Mumbai Crime Branch arrests wanted drug smuggler Lalit Patil after massive nationwide manhunt in connection with record ₹252 crore pharmaceutical drug seizure case.
Leading pharmaceutical experts gathered in Chandigarh for a crucial conference on drug quality and regulatory compliance, focusing on improving manufacturing practices and patient safety across India.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
US stocks traded flat as investors await Tesla's crucial earnings report while Netflix shares tumble 8% following mixed quarterly results. Key market insights and analysis.
Indian pharmaceutical leader Biocon Biologics partners with Civica to disrupt US insulin market with affordable alternatives, while also eyeing anti-obesity therapy opportunities.
Netflix faces significant stock market pressure as Q3 earnings disappoint investors. Discover the key factors behind the 6.5% drop and what it means for the streaming giant's future.
World Health Organization reports India making progress on drug regulation but warns more action needed to prevent toxic cough syrup incidents that have claimed lives globally.
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
As US-China tensions simmer and credit concerns linger, Wall Street turns to mega-cap earnings from Tesla, Meta, and Microsoft for market direction. Discover how global markets are reacting.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
US stock markets staged a powerful rally as strong corporate earnings and cooling inflation fueled investor risk appetite. Discover which sectors led the charge and what's next for global markets.
Kotak Institutional Equities reports India's corporate earnings downgrade cycle is ending. Sanjeev Prasad highlights improving fundamentals, FPI interest, and economic growth drivers set to boost India Inc performance.
Uttar Pradesh authorities intercept massive consignment of prohibited cough syrup worth ₹3 crore in ongoing war against illegal pharmaceutical trade.
Massive drug crackdown in Uttar Pradesh as officials confiscate illegal cough syrup worth ₹3 crore from a Sonbhadra warehouse. Investigation reveals sophisticated smuggling operation.
Biocon Executive Chairperson Kiran Mazumdar-Shaw firmly denies Karnataka Deputy CM DK Shivakumar's claims about the company's Bengaluru expansion plans, asserting their commitment to the state is unwavering.
Get ready for a blockbuster week as corporate India's Q2 earnings season hits high gear. Hindustan Unilever, SBI Life Insurance, and over 40 other companies set to unveil their financial performance, offering crucial insights into market direction and eco
Discover how India is transforming its approach to pediatric cough syrups with new regulations, bitter-tasting alternatives, and enhanced safety measures following global health concerns.
Discover how Luka Dončić built his staggering net worth in 2025. From NBA contracts to endorsements, explore the financial journey of the Los Angeles Lakers superstar.
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
Major Indian banking and cement stocks including HDFC Bank, ICICI Bank, Yes Bank, PNB, Ultratech Cement and UTI Asset Management to announce Q2 FY24 results today. Get expert analysis on what to expect from these key players.
Mukesh Ambani's Reliance Industries reports stellar Q2 results with 16% profit surge, fueled by robust performance in Jio and retail sectors. Discover how India's largest conglomerate continues its growth trajectory.